40 Results for "

DNA DSB

" in MedChemExpress (MCE) Product Catalog:
Products (40)

40 Results for "DNA DSB" in MCE Product Catalog:

11
11 Publications Verification
Cat. No.: HY-19959
CAS No.: 1198097-97-0
Target:  

ATM/ATR Apoptosis

Research Areas:  

Cancer

Mirin is a potent Mre11-Rad50-Nbs1 (MRN) complex inhibitor. Mirin prevents MRN-dependent activation of ATM (IC50=12 μM) without affecting ATM protein kinase activity, and it inhibits Mre11-associated exonuclease activity. Mirin abolishes the G2/M checkpoint and homology-dependent repair in mammalian cells. Mirin prevents ATM activation in response to DNA double-strand breaks (DSBs) and blocks homology-directed repair (HDR) in mammalian cells .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-B1357
CAS No.: 71-63-6
Digitoxin is an anti-cancer agent. Digitoxin induces apoptosis, inhibits influenza cytokine storm, causes DNA double-stranded breaks (DSBs) and blocks the cell cycle at the G2/M phase. Digitoxin induces calcium uptake into cells by forming transmembrane calcium channels and can be used for research of heart failure .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-19939S
CAS No.: 1476074-39-1
Synonyms: M9831
VX-984 is an orally active, potent, selective and BBB-penetrated DNA-PK inhibitor. VX-984 efficiently inhibits NHEJ (non-homologous end joining) and increases DSBs (DNA double-strand breaks). VX-984 can be used for glioblastomas (GBM) and non-small cell lung cancer (NSCLC) research. VX-984 is a de novo deuterium .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-17469
CAS No.: 103766-25-2
Synonyms: Gimestat
Gimeracil, a component of an oral fluoropyrimidine derivative S-1, inhibits DNA DSB repair and is a potent inhibitor of DPYD (dihydropyrimidine dehydrogenase, DPD) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10534
CAS No.: 175414-77-4
Purity:  99.26%
Synonyms: SNS-595; Vosaroxin; AG 7352
Target:  

Topoisomerase Apoptosis

Research Areas:  

Cancer

Voreloxin (SNS-595; Vosaroxin; AG 7352) is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16518
CAS No.: 175519-16-1
Synonyms: SNS-595 Hydrochloride; Vosaroxin Hydrochloride; AG 7352 Hydrochloride
Target:  

Topoisomerase Apoptosis

Research Areas:  

Cancer

Voreloxin Hydrochloride is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-110111
CAS No.: 1380782-27-3
Purity:  99.04%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

T2AA is a monoubiquitinated proliferating cell nuclear antigen (PCNA) inhibitor that prevents DNA repair, increases double-strand break (DSB) formation and promotes necroptosis and cell cycle arrest in G1 phase .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111183
CAS No.: 9014-02-2
Purity:  ≥99.0%
Synonyms: Zinostatin; Vinostatin
Neocarzinostatin (solution), a potent DNA-damaging, anti-tumor antibiotic, recognizes double-stranded DNA bulge and induces DNA double strand breaks (DSBs). Neocarzinostatin induces apoptosis. Neocarzinostatin has potential for EpCAM-positive cancers treatment .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13703A
CAS No.: 55661-38-6
Purity:  98.22%
Synonyms: ACNU
Nimustine hydrochloride (ACNU) is the hydrochloride salt form of Nimustine (HY-13703). Nimustine hydrochloride is an alkylating agent, which induces DNA double-strand breaks (DSBs) and inter-strand crosslinks (ICLs), thereby activating the DNA damage response (DDR) signaling pathway. Nimustine hydrochloride activates p38 MAPK/JNK signaling pathway, and exhibits antitumor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113064
CAS No.: 2897-21-4
Purity:  ≥99.0%
Selenocystine is a broad-spectrum anti-cancer agent. Selenocystine induces DNA damage in HepG2 cells, particularly in the form of DNA double strand breaks (DSBs). Selenocystine exhibits great promise as a therapeutic or adjuvant agent targeting DNA repair for cancer treatment .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121862
CAS No.: 2101208-44-8
Purity:  99.73%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

CM03 is a potent DNA G-quadruplexes (G4s) ligand. CM03 can stabilise G4s, downregulating more G4-containing genes as well as increasing incidence of double-strand break events (DSBs) due to torsional strain on DNA and chromatin structure. CM03 has selective potency for pancreatic cancer cells .
loading...
    loading...
Cat. No.: HY-100705
CAS No.: 20357-25-9
Purity:  98.76%
Synonyms: 6-Nitroveratraldehyde
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

DMNB (6-Nitroveratraldehyde) is a photolabile proton donor that releases acidic substances when excited at a wavelength of 405 nM. DMNB can be used for the synthesis of no-carrier-added 6-[18F]fluoro-L-DOPA (6-FDOPA). DMNB is also applicable to the preparation of o-nitroaryl-bis (5-methylfur-2-yl) methanes and the synthesis of alpha-asarone (HY-N0700). DMNB is an enzyme involved in the non-homologous end joining (NHEJ) pathway responsible for DNA double-strand break (DSB) repair. DMNB can be used in PET studies of the dopaminergic system .
loading...
    loading...
Cat. No.: HY-160096
CAS No.: 1360628-91-6
Research Areas:  

Cancer

M3541 is an orally effective DNA-dependent protein kinase (DNA-PK) inhibitor . M3541 inhibits ionizing radiation-induced ATM autophosphorylation and phosphorylation of downstream substrates (KAP1, CHK2, p53), blocks DSB end resection and homologous recombination repair, and simultaneously induces non-homologous end joining, G2-M phase arrest, polyploidization, and cell death. M3541 can be used for research on solid tumors, acute myeloid leukemia, non-small cell lung cancer, triple-negative breast cancer, etc. .
loading...
    loading...
Cat. No.: HY-115531
CAS No.: 1648707-58-7
Purity:  98.84%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

UNC-2170 is a functionally active, fragment-like ligand for 53BP1 (IC50=29 µM; Kd=22 µM). UNC-2170 shows at least 17-fold selectivity for 53BP1 as compared to nine other methyl-lysine (Kme) reader proteins. 53BP1 is a Kme binding protein that plays a central role in DNA Damage Repair (DDR) pathways and is recruited to sites of double-strand breaks (DSB) .
loading...
    loading...
Cat. No.: HY-W543137
CAS No.: 727721-37-1
Pt-ttpy, a metallo-organic complex and potent G-quadruplex ligand, effectively triggers substantial telomere-related DNA damage in cancer cells by inhibiting telomerase and/or telomere functions, while also causing various chromatin abnormalities during mitosis, such as chromatin bridges, ultrafine bridges (UFBs), and double-stranded breaks (DSBs).
loading...
    loading...
Cat. No.: HY-Q04764
CAS No.: 1005178-02-8
Research Areas:  

Cancer

TI17 is an inhibitor of the thyroid hormone receptor-interacting protein Trip13 and has anticancer activity. TI17 effectively inhibits multiple myeloma (MM) cell proliferation and induces cell cycle arrest and apoptosis. Trip13 is an AAA-ATPase that mediates double-strand break (DSB) repair; TI17 inhibits Trip13 function and increases DNA damage .
loading...
    loading...
Cat. No.: HY-115552
CAS No.: 1551355-46-4
Purity:  99.01%
Target:  

PARP

Research Areas:  

Cancer

Simmiparib is a highly potent and orally active PARP1 and PARP2 inhibitor with IC50 values of 1.75 nM and 0.22 nM, respectively. Simmiparib has more potent PARP1/2 inhibition than its parent Olaparib (HY-10162). Simmiparib induces DNA double-strand breaks (DSB) accumulation and G2/M arrest in homologous recombination repair (HR)-deficient cells, thereby inducing apoptosis. Simmiparib exhibits remarkable anticancer activities in cells and nude mice bearing xenografts .
loading...
    loading...
Cat. No.: HY-176165
CAS No.: 3081246-18-3
Research Areas:  

Cancer

CDK9/EZH2-IN-1 (Compound D16) is a CDK9/EZH2 dual-target inhibitor (IC50: 83.9/108.6 nM). CDK9/EZH2-IN-1 induces apoptosis and DNA double-strand breaks (DSBs). CDK9/EZH2-IN-1 inhibits the proliferation activity of MKN45, MDA-MB-453 and SW620 cancer cells (IC50 values are 136.3, 171.3 and 315.7 nM, respectively) .
loading...
    loading...
Cat. No.: HY-100707
CAS No.: 404009-40-1
Purity:  99.06%
Target:  

DNA-PK Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

IC 86621 is a potent DNA-dependent protein kinase (DNA-PK) inhibitor, with an IC50 of 120 nM. IC 86621 also acts as a selective and reversible ATP-competitive inhibitor.IC 86621 inhibits DNA-PK mediated cellular DNA double-strand break (DSB) repair (EC50=68 µM). IC 86621 increases DSB-induced antitumor activity without cytotoxic effects. IC 86621 can protects rheumatoid arthritis (RA) T cells from apoptosis .
loading...
    loading...
Cat. No.: HY-149348
CAS No.: 3052259-89-6
Research Areas:  

Cancer

DiPT-4 is a dual TOP1/PARP1 inhibitor that induces massive DNA double-strand breaks (DSBs), cell cycle arrest, and apoptosis in cancer cells. DiPT-4 has the potential to overcome cancer drug resistance .
loading...
    loading...